EMA Authorised: Entacapone Orion (entacapone) — Orion Corporation

View source ↗

Summary

Entacapone Orion has been authorised in the EU for Parkinson's disease; Orion Corporation is the marketing authorisation holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Entacapone Orion (entacapone)

Snippet

Status: Authorised. Therapeutic area: Parkinson Disease. MAH: Orion Corporation. Decision date: 20/09/2024